Literature DB >> 12560124

Local inflammation increases vanilloid receptor 1 expression within distinct subgroups of DRG neurons.

Fumimasa Amaya1, Kentaro Oh-hashi, Yoshihisa Naruse, Norio Iijima, Masashi Ueda, Goshun Shimosato, Makoto Tominaga, Yoshifumi Tanaka, Masaki Tanaka.   

Abstract

Vanilloid receptor 1 (VR1) is essential to the development of inflammatory hyperalgesia. We investigated whether inflammation can increase in VR1 positive neuronal profiles in rat DRG neurons using histochemical methods. We also used size frequency analysis and double staining with several neuronal markers to investigate whether or not inflammation alters VR1 expression. Inflammation induced a 1.5-fold increase in percentage of VR1-like immunoreactivity (LI) positive profiles per total neuronal profiles, suggesting that the number of heat and pH sensitive neurons increase during inflammation. Area frequency histograms showed that VR1 expression increased in small and medium-sized neurons after inflammation. Double labeling of VR1 with NF200 showed that VR1 positive neurons with NF200 positive profiles significantly increased, indicating that the medium-sized VR1 positive neurons were neurons with myelinated A-fibers. Local inflammation thus increases in VR1 protein level within distinct subgroups of DRG neurons that may participate in the development and maintenance of inflammatory hyperalgesia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12560124     DOI: 10.1016/s0006-8993(02)03972-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  61 in total

Review 1.  Transient receptor potential channels in pain and inflammation: therapeutic opportunities.

Authors:  Mark A Schumacher
Journal:  Pain Pract       Date:  2010-03-02       Impact factor: 3.183

2.  Lack of potentiating effect of increasing temperature on responses to chemical activators in vagal sensory neurons isolated from TRPV1-null mice.

Authors:  Dan Ni; Lu-Yuan Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-08-29       Impact factor: 5.464

3.  Rapid, opioid-sensitive mechanisms involved in transient receptor potential vanilloid 1 sensitization.

Authors:  Irina Vetter; Wei Cheng; Madusha Peiris; Bruce D Wyse; Sarah J Roberts-Thomson; Jie Zheng; Gregory R Monteith; Peter J Cabot
Journal:  J Biol Chem       Date:  2008-05-15       Impact factor: 5.157

Review 4.  The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence.

Authors:  Yanju Bao; Yebo Gao; Liping Yang; Xiangying Kong; Jing Yu; Wei Hou; Baojin Hua
Journal:  Channels (Austin)       Date:  2015-07-15       Impact factor: 2.581

5.  Peripheral inflammation affects modulation of nociceptive synaptic transmission in the spinal cord induced by N-arachidonoylphosphatidylethanolamine.

Authors:  Vladimir Nerandzic; Petra Mrozkova; Pavel Adamek; Diana Spicarova; Istvan Nagy; Jiri Palecek
Journal:  Br J Pharmacol       Date:  2017-06-11       Impact factor: 8.739

6.  The role of transient receptor potential vanilloid 1 in mechanical and chemical visceral hyperalgesia following experimental colitis.

Authors:  A Miranda; E Nordstrom; A Mannem; C Smith; B Banerjee; J N Sengupta
Journal:  Neuroscience       Date:  2007-08-23       Impact factor: 3.590

Review 7.  Anandamide and vanilloid TRPV1 receptors.

Authors:  Ruth A Ross
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

8.  Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice.

Authors:  Lauren E Ta; Allan J Bieber; Susan M Carlton; Charles L Loprinzi; Philip A Low; Anthony J Windebank
Journal:  Mol Pain       Date:  2010-03-05       Impact factor: 3.395

9.  TRPV1: a target for next generation analgesics.

Authors:  Louis S Premkumar; Parul Sikand
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

10.  Expression and function of proton-sensing G-protein-coupled receptors in inflammatory pain.

Authors:  Ying-Ju Chen; Chia-Wei Huang; Chih-Shin Lin; Wen-Han Chang; Wei-Hsin Sun
Journal:  Mol Pain       Date:  2009-07-14       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.